Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992584549> ?p ?o ?g. }
- W1992584549 endingPage "230" @default.
- W1992584549 startingPage "205" @default.
- W1992584549 abstract "Despite intense debate on the benefits of cholesterol lowering, the use of lipid-lowering drugs has risen substantially in most countries. This change in attitude has accompanied the appreciation of data from initial observational studies on large cohorts that established the link between elevated serum cholesterol and coronary heart disease and randomized controlled trials of cholesterol lowering that demonstrated improvements in coronary morbidity and mortality seen in patients with or without coronary heart disease. Data are now accumulating on the effects of lowering serum triglyceride levels in improving coronary risk. More studies are still required, but metabolic studies indicate that high serum triglycerides are a marker for the presence of atherogenic small dense low-density lipoproteins. Low concentrations of high-density lipoprotein cholesterol is also a marker for coronary risk, but the case for increasing levels by drugs is unclear. The rationale for the use of lipid-lowering drugs becomes more evident with an understanding of the mechanisms that cause hyperlipidaemia. In addition to serum lipid values, a good clinical history and examination are an essential part of assessing coronary risk. Certain groups, such as women, children, elderly people and patients with genetic hyperlipidaemias or liver or renal disease, need a special approach to therapy. The better tolerability and widespread use of the newer lipid-lowering drugs have raised issues of cost effectiveness. New lipid-lowering drugs are being developed, and there is some evidence that existing lipid-lowering drugs may produce benefit beyond that related to lipid lowering." @default.
- W1992584549 created "2016-06-24" @default.
- W1992584549 creator A5023104493 @default.
- W1992584549 date "1998-10-01" @default.
- W1992584549 modified "2023-09-27" @default.
- W1992584549 title "Lipid-Lowering Drugs in the Management of Hyperlipidaemia" @default.
- W1992584549 cites W105987659 @default.
- W1992584549 cites W10628619 @default.
- W1992584549 cites W150670263 @default.
- W1992584549 cites W1510898619 @default.
- W1992584549 cites W1532187436 @default.
- W1992584549 cites W1547617136 @default.
- W1992584549 cites W1569194223 @default.
- W1992584549 cites W1832709945 @default.
- W1992584549 cites W1848464647 @default.
- W1992584549 cites W18666461 @default.
- W1992584549 cites W1960974308 @default.
- W1992584549 cites W1963842597 @default.
- W1992584549 cites W1965553518 @default.
- W1992584549 cites W1965665454 @default.
- W1992584549 cites W1966817707 @default.
- W1992584549 cites W1969927159 @default.
- W1992584549 cites W1970138556 @default.
- W1992584549 cites W1970456338 @default.
- W1992584549 cites W1973331125 @default.
- W1992584549 cites W1978203452 @default.
- W1992584549 cites W1978666616 @default.
- W1992584549 cites W1978761831 @default.
- W1992584549 cites W1981006612 @default.
- W1992584549 cites W1983531379 @default.
- W1992584549 cites W1984154504 @default.
- W1992584549 cites W1984654906 @default.
- W1992584549 cites W1985798759 @default.
- W1992584549 cites W1986443233 @default.
- W1992584549 cites W1989213665 @default.
- W1992584549 cites W1990884632 @default.
- W1992584549 cites W1991325639 @default.
- W1992584549 cites W1991899835 @default.
- W1992584549 cites W1992338255 @default.
- W1992584549 cites W1992859964 @default.
- W1992584549 cites W1993181745 @default.
- W1992584549 cites W1995268045 @default.
- W1992584549 cites W1996447072 @default.
- W1992584549 cites W1997348520 @default.
- W1992584549 cites W1998997595 @default.
- W1992584549 cites W2002691808 @default.
- W1992584549 cites W2003185073 @default.
- W1992584549 cites W2003307830 @default.
- W1992584549 cites W2004145281 @default.
- W1992584549 cites W2004373877 @default.
- W1992584549 cites W2005786831 @default.
- W1992584549 cites W2006392410 @default.
- W1992584549 cites W2006705370 @default.
- W1992584549 cites W2007542782 @default.
- W1992584549 cites W2009113903 @default.
- W1992584549 cites W201557267 @default.
- W1992584549 cites W2016464689 @default.
- W1992584549 cites W2017766892 @default.
- W1992584549 cites W2018003834 @default.
- W1992584549 cites W2018715171 @default.
- W1992584549 cites W2020632420 @default.
- W1992584549 cites W2024120744 @default.
- W1992584549 cites W2025139995 @default.
- W1992584549 cites W2025726242 @default.
- W1992584549 cites W2025804069 @default.
- W1992584549 cites W2026018533 @default.
- W1992584549 cites W2029833995 @default.
- W1992584549 cites W2030628284 @default.
- W1992584549 cites W2031113176 @default.
- W1992584549 cites W2034139682 @default.
- W1992584549 cites W2036350809 @default.
- W1992584549 cites W2038410275 @default.
- W1992584549 cites W2044172249 @default.
- W1992584549 cites W2044685854 @default.
- W1992584549 cites W2045337701 @default.
- W1992584549 cites W2045622064 @default.
- W1992584549 cites W2046028995 @default.
- W1992584549 cites W2046402669 @default.
- W1992584549 cites W2046942878 @default.
- W1992584549 cites W2047419091 @default.
- W1992584549 cites W2047709447 @default.
- W1992584549 cites W2048978769 @default.
- W1992584549 cites W2050758709 @default.
- W1992584549 cites W2052195019 @default.
- W1992584549 cites W2052578635 @default.
- W1992584549 cites W2052751621 @default.
- W1992584549 cites W2058377594 @default.
- W1992584549 cites W2059742307 @default.
- W1992584549 cites W2060564897 @default.
- W1992584549 cites W2064859479 @default.
- W1992584549 cites W2066190294 @default.
- W1992584549 cites W2067487203 @default.
- W1992584549 cites W2067767944 @default.
- W1992584549 cites W206782953 @default.
- W1992584549 cites W2068195970 @default.
- W1992584549 cites W2068531234 @default.
- W1992584549 cites W2069195156 @default.
- W1992584549 cites W2070999659 @default.